Maria Teresa Petrucci, Anna Levi, Sara Bringhen, Simona Scotti, Fabiana Gentilini, Simone Russo, Agostina Siniscalchi, Alessandra Larocca, Sara Grammatico, Mario Boccadoro, Robin Foà and Antonio Palumbo Bortezomib, melphalan, and prednisone in elderly patients with relapsed/refractory multiple myeloma Cancer 119
Version of Record online: 23 OCT 2012 | DOI: 10.1002/cncr.27820
The results from this study demonstrate that bortezomib and melphalan can be administered safely and effectively to elderly patients with relapsed/refractory multiple myeloma. The schedule is specially tailored for elderly patients who are not eligible for intensive treatment and who require the assurance of an advantage in terms of response and survival and along with an associated low rate of toxicity.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field